WuXi Biologics
Offering End-to-End Solutions
Suzhou, China
Suzhou, China
WuXi Vaccines’ Suzhou site is in Suzhou Industrial Park, a 1.5 hour-drive from Shanghai Pudong International Airport. The BSL-1 and BSL-2 facilities offer clinical and commercial manufacturing services for drug substance (DS), drug product (DP) and packaging & labeling.
Current capability
DS BSL-1
- CHO platform with single-use bioreactors: 50, 250, 500, and 1,000 L
- Microbial platform with stainless steel fermenters: 200 L, up to 500 L
DS BSL-2 plug-and-play
- Cell Banking
- Microbial platform with stainless steel fermenters: 100 L, up to 200 L
- Viral platform: Different scales of T-Flasks, Cell stacks, up to 500 L single-use bioreactors
DP:
B+A oRABS filling line:
- For both liquid and lyophilization vial fills
- Equipped with a 1 × 5 m2 freeze dryer
- Capable for liquid, lyo, suspension and emulsion filling in vial
- Filling volume:
-
- Small DS volume suspension filling of 1 – 5 L
- Up to 200 L for liquid
- Up to 50 L for suspension and emulsion
High speed isolator filling line
- Equipped with 3 × 25 m2 lyophilizer
- Capable for liquid, lyo, suspension & emulsion filling in vials
- Annual capacity of 30 million vials
World-class Quality
We provide quality assurance, quality control, and operational systems that meet or exceed worldwide regulatory standards. Our premier quality systems are approved by multiple global regulatory agencies for a wide variety of biologics and vaccines, including US FDA, EMA, ANVISA, NMPA and WHO.
Regulatory Inspections Passed
Facilities Certified
Million Doses Delivered
Countries Served in the Fight Against COVID-19
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?